Biological Safety Testing Market is expected to grow at a significant rate during the forecast period 2019-2025. Biological safety testing services are continuously being adopted for safety purposes. After the successful development of the biotechnology-derived products and technology into diagnosis, prevention, and treatment, it is being compared against set standards in order to avoid potential safety concerns that arise due to biological features and complex structure of the products. Biological safety testing ensures the non-contamination of biological products and apparatuses. Due to advancement in biotechnology and pharmaceutical industry, adoption of standard safety techniques is significantly growing. Various procedures are being adopted to ensure the absence of bacteria and viruses in the developed products and services. Global biological safety market is increasing year-over-year with a substantial rate. With the rising advancement in the technology, structural and biological complexity is increasing in the products for various medical purpose. Therefore, before being adopted for medical services, levels of biological safety testing are becoming a necessity for market players and research institutes. Global biological safety testing market is promising a significant growth and is estimated to grow with the increasing market opportunities in the forecast period.

Global biological safety testing market is segmented on the basis of product into instruments, and reagents and kits. On the basis of test type, the market is segmented into sterility test, bioburden test, residual host contamination test, cell line authentication, and characterization test and others. Reagents and kits comprise the major market share due to use of reagents in a maximum of safety testing procedures. They are extensively used for clinical research and laboratories.

Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is leading the global biological safety testing market due to continuous advancements in biotechnology and pharmaceuticals sector. Moreover, growing support from the government is contributing to the market growth in the region. North America is followed by Europe in the global biological safety testing market. Asia-Pacific is growing substantially due to growing drug development activities in the region. Additionally, regulatory support is pacing the market growth in the region. RoW is also considered as a potential market due to growing awareness among people for various medical devices and tests.

Global biological safety testing market comprises of various companies such as Charles River Laboratories Inc., Lonza Group Ltd., Merck KGaA, Neopharm Labs Inc., Sartorius Stedim BioOutsource Ltd., SGS SA, and others. The companies are focused on product innovation through investing more in R&D activities on medical safety tests. Companies are focused on expanding market presence through operational tie-ups with various research centers across the globe. Moreover, mergers and acquisition remain one of the focused strategies for market players operating in domestic and international markets.

Research Methodology

The market study of the global biological safety testing market is incorporated by extensive primary and secondary research conducted by a research team at OMR.  Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Authentic Public Databases
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.

The report is intended for biotech and pharmaceutical companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

Global biological safety testing market is segmented on the basis of regional outlook and following segments:

• Global Biological Safety Testing Market Research and Analysis by Product
• Global Biological Safety Testing Market Research and Analysis by Test Type
• Global Biological Safety Testing Market Research and Analysis by Geography

The Report Covers

• Comprehensive research methodology of the global biological safety testing market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global biological safety testing market.
• Insights about market determinants which are stimulating the global biological safety testing market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.